New SDK Release: Build secure medical apps faster with our tools for EHRs, devices, and patient-doctor solutions. Explore CardinalSDK

Hoofdmenu
Producten
Cardinal Backend & SDK Cardinal Data Exchange Module Cardinal Free Health Connector Gebruikscases
Nieuws
Neem contact op
Back to blog

November 14, 2023

Top MedTech Startups To Watch In 2024

post illustration

Introduction

The blend of technology and healthcare is sparking a new era of innovation, and in 2024, MedTech startups are leading the charge in transforming how we experience healthcare. These startups are not just in the game — they’re changing it.

They’re introducing fresh ideas, creating advanced medical devices, and rethinking how we approach healthcare challenges. From cutting-edge gadgets to smart diagnostic tools, they’re reshaping the way healthcare is delivered.

In this article, we’ll take a closer look at 10 game-changing MedTech startups in 2024. As we explore the stories of these startups, it becomes clear that they’re not just revolutionizing healthcare. They’re making it smarter, more efficient, and more focused on the people it serves.

Sana Health

Sana Health is changing how we deal with chronic pain.

At the heart of their breakthrough technology is a device that harnesses the power of audio-visual stimulation to modulate the user’s nervous system. This approach offers a drug-free alternative for individuals grappling with chronic pain conditions or just looking for a deep meditative relief.

The neurostimulation wearable by Sana Health represents a departure from traditional pain management methods, opting for a non-invasive and holistic solution. By leveraging audio and visual stimuli, the device taps into the body’s natural mechanisms, aiming to recalibrate the perception of pain.

Sana Health’s commitment to offering a safer, non-addictive avenue for chronic pain relief could catalyze a revolution in how we approach and alleviate persistent pain conditions. As their technology continues to evolve, it holds the promise of not only mitigating the immediate discomfort of chronic pain but also contributing to a broader shift in pain management paradigms, prioritizing holistic well-being and long-term health outcomes.

FindMeCure

FindMeCure is a passionate advocate for medical innovation. Their main contribution is an extensive database that compiles ongoing medical trials from all around the world. This initiative is a goldmine of information, tailored to specific diseases, and a valuable resource for patients, researchers, and healthcare professionals alike. With a repository of over 60,000 trials, FindMeCure has taken significant steps to make critical medical trial data easily accessible.

The company is making a global impact, having reached out to over 370,000 individuals. They’re all about connecting patients looking for potential treatments, researchers conducting trials, and healthcare professionals staying up-to-date with the latest advancements. This way, it is playing a pivotal role in leveling the playing field when it comes to medical knowledge.

As FindMeCure continues to grow, their support for medical progress and collaboration within the healthcare community becomes increasingly vital. They’re all about fostering new ideas and teamwork in the ever-evolving healthcare field, making a real impact on the future of medicine.

LegWorks

LegWorks is a company dedicated to improving the lives of amputees. They focus on making prosthetic solutions that are both affordable and easy to use.

One of their standout products is the All-Terrain Knee (AT-Knee), which is designed to provide better stability and mobility for amputees, especially on uneven surfaces.

The company works hard to keep costs low so that more individuals can afford high-quality prosthetics, but their mission goes beyond just creating products. LegWorks collaborates with healthcare organizations, charities, and governments to ensure that their technology reaches people all over the world. In doing so, they are making a significant impact by giving amputees greater independence and a better quality of life.

HeartKinetics

HeartKinetics is a dynamic MedTech startup on a mission to revolutionize healthcare by placing the power of heart health in your hands. Their story is one of passion and commitment to cardiovascular well-being, driven by a vision to transform the way we monitor and manage our hearts.

HeartKinetics’ innovation lies in their cutting-edge wearable technology.

Imagine having real-time insights into your heart’s performance at your fingertips. It’s like having a personal heart health coach with you 24/7, helping you detect irregularities and potential issues before they become serious concerns.

HeartKinetics empowers you to take charge of your heart health, making it not just a priority but a pleasure to keep your heart in tip-top shape.

But what truly sets HeartKinetics apart is their unwavering dedication to inclusivity. Their technology is designed to be user-friendly and affordable, ensuring that everyone, regardless of their background or lifestyle, can benefit from early detection and proactive heart health management. As they continue to fine-tune and expand their technology, HeartKinetics is not just promoting heart health — they’re igniting a heart health revolution that promises longer, healthier lives for all.

Proov

Proov’s revolutionary progesterone test strips are the brainchild of Dr. Amy Beckley, a remarkable woman who endured a challenging journey of infertility, including two rounds of IVF and seven heartbreaking pregnancy losses spanning three years.

Dr. Beckley’s personal experience led her to discover that her fertility struggles were linked to low progesterone levels. In response, she developed these innovative test strips, driven by a deep desire to spare other women the agony of misdiagnosis and lengthy medical investigations.

Proov’s progesterone tests have received FDA approval, granting women access to crucial hormonal insights without the need for a doctor’s office visit or blood tests. This FemTech company has already secured a total $21 million in funding (according to Crunchbase data), marking a significant step towards empowering women in their reproductive health journey.

Biospectal

Biospectal’s mission is nothing short of game-changing.

Imagine measuring your blood pressure accurately and effortlessly with just your smartphone’s camera. Biospectal makes this vision a reality.

Their journey began with a deep-rooted commitment to improving healthcare access for everyone. They recognized the need for a simpler way to monitor blood pressure, and they’ve delivered a unique solution.

Whether you’re at home or on the move, Biospectal ensures that crucial health data is right at your fingertips. The company’s dedication to democratizing healthcare is reshaping the landscape of healthcare technology by offering user-friendly solutions that bring accuracy and convenience to the forefront. As they continue to innovate, Biospectal is poised to transform lives and elevate healthcare standards on a global scale.

ABLE Human Motion

ABLE Human Motion based in Barcelona is making waves in the world of medical technology with their mission to empower individuals facing mobility challenges.

ABLE Human Motion’s greatest innovation is their flagship product, the ABLE Exoskeleton. This wearable device is designed to assist individuals with lower limb disabilities in regaining their mobility. What sets it apart is its user-friendly and intuitive design, making it accessible to a wide range of users.

The ABLE Exoskeleton empowers individuals to stand up, walk, and regain a sense of freedom that was once out of reach. The company invests heavily in research and development to ensure their solutions meet and exceed user expectations, making a real impact in the field.

Recognized and supported by both the medical community and investors, ABLE Human Motion’s journey showcases the transformative potential of technology in enhancing the quality of life for individuals facing mobility issues. As they continue to push boundaries and innovate, they are paving the way for a future where mobility is accessible to all, regardless of limitations.

PathAI

Path AI is a leading player in the field of medical technology, focused on transforming pathology through innovative artificial intelligence (AI) solutions. Their mission is clear — to revolutionize the way diseases are detected and diagnosed, improving accuracy and efficiency in healthcare.

The secret sauce is their cutting-edge AI technology. By leveraging machine learning, they have empowered pathologists and medical professionals to analyze and interpret medical images, especially pathology slides, with unparalleled precision. This breakthrough enables quicker and more precise diagnoses, ultimately leading to better patient outcomes.

Path AI stands out for its collaborative approach with healthcare experts. Rather than replacing pathologists, their AI solutions work alongside them, reducing the potential for human error and expediting diagnosis times. This cooperative effort has garnered recognition and support from both the medical community and investors, underscoring the potential of AI in healthcare.

Shockwave Medical

Shockwave Medical is an innovative MedTech startup revolutionizing the field of cardiovascular care. Founded with a vision to transform the treatment of calcified cardiovascular disease, Shockwave Medical has developed groundbreaking technology to address this challenging medical condition.

At the heart of Shockwave’s innovation is their FDA-approved Intravascular Lithotripsy (IVL) technology, a non-invasive and highly effective approach to treating calcified arteries. By using sonic pressure waves to gently fracture calcium deposits, IVL enables interventional cardiologists to deliver stents and other therapeutic devices with greater precision and ease.

This breakthrough technology not only improves the safety and success of cardiovascular procedures but also enhances patient outcomes. Shockwave Medical continually strives to expand the applications of their IVL technology, offering new hope to patients with challenging vascular conditions.

With their cutting-edge solutions, the company is poised to revolutionize the treatment landscape for cardiovascular disease, providing safer and more effective options for patients and healthcare professionals alike.

Vicarious Surgical

Vicarious Surgical is an emerging MedTech startup that’s making significant strides in the world of minimally invasive surgery. Founded with a bold vision to revolutionize surgical procedures, the company is at the forefront of developing groundbreaking technology aimed at enhancing the capabilities of surgeons and improving patient outcomes.

Their platform offers a unique and immersive surgical experience that combines the precision of robotics with the skills of human surgeons. By leveraging VR and AR technology, surgeons can perform complex procedures with greater accuracy, control, and insight, all while minimizing the invasiveness of the surgery. This approach not only reduces patient recovery times but also enhances surgical outcomes, ultimately improving the quality of care.

Vicarious Surgical’s commitment to advancing the field of minimally invasive surgery is reflected in their ongoing research and development efforts. They continuously work to expand the applications of their technology, exploring new horizons in the world of surgery. With their innovative solutions, Vicarious Surgical is poised to reshape the future of surgical care, providing surgeons with powerful tools to deliver safer, more effective procedures and offering patients a path to faster recovery and improved health.

Conclusion

The MedTech startups mentioned here are at the forefront of a healthcare revolution, bringing forth innovative solutions to improve patient outcomes, increase accessibility, and streamline medical practices.

In 2024 and beyond, these startups along with many others like them, will continue to shape the future of healthcare, driving advancements that benefit both healthcare professionals and the individuals they serve. As we witness the unfolding of this MedTech era, keeping a close eye on these 10 startups is crucial for understanding the evolving landscape of healthcare innovation.

Back

Terms of use

www.iCure.com

1. RECITALS

ICure SA is incorporated in Geneva, Switzerland, with a registered office at Rue de la Fontaine 7, 1211 Geneva, Switzerland registered in the commercial registry under CHE-270.492.477 (“iCure”).

These Terms of Use constitute a legally binding agreement made between you, whether personally or on behalf of an entity (“you”) and iCure SA (“we,” “us” or “our”), concerning your access to and use of the https://www.icure.com website as well as any other media form, media channel, mobile website or mobile application related, linked, or otherwise connected thereto (collectively, the “Website”).

When you accept, these Terms form a legally binding agreement between you and iCure. If you are entering into these Terms on behalf of an entity, such as your employer or the company you work for, you represent that you have the legal authority to bind that entity.

PLEASE READ THESE TERMS CAREFULLY. BY REGISTERING FOR, ACCESSING, BROWSING, AND/OR OTHERWISE USING THE iCURE, YOU ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD, AND AGREE TO BE BOUND BY THESE TERMS. IF YOU DO NOT AGREE TO BE BOUND BY THESE TERMS, DO NOT ACCESS, BROWSE, OR OTHERWISE USE THE ICURE WEBSITE.

iCure may, in its sole discretion, elect to suspend or terminate access to, or use of the iCure to anyone who violates these Terms.

All users who are minors in the jurisdiction in which they reside (generally under the age of 18) must have the permission of, and be directly supervised by, their parent or guardian to use the Website. If you are a minor, you must have your parent or guardian read and agree to these Terms of Use prior to you using the Website.

The original language of these Terms and Use is English. In case of other translations provided by iCure, the English version shall prevail.

2. INTELLECTUAL PROPERTY RIGHTS

The Content of the documentation stated on this Website is ours. All Marks, Content that concern iCure cannot be copied, reproduced, aggregated, republished, uploaded, posted, publicly displayed, encoded, translated, transmitted, distributed, sold, licensed, or otherwise exploited for any commercial purpose whatsoever, without our express prior written permission.

Provided that you are eligible to use the Website, you are granted a limited license to access and use the Website and to download or print a copy of any portion of the Content to which you have properly gained access solely for your personal, non-commercial use. We reserve all rights not expressly granted to you in and to the Website, the Content, and the Marks.

3. USER REPRESENTATIONS

By using the Website, you represent and warrant that:

  1. All registration information you submit will be true, accurate, current, and complete; you will maintain the accuracy of such information and promptly update such registration information as necessary.
  2. You have the legal capacity, and you agree to comply with these Terms of Use.
  3. You are not under the age of 13.
  4. Not a minor in the jurisdiction in which you reside, or if a minor, you have received parental permission to use the Website.
  5. You will not access the Website through automated or non-human means, whether through a bot, script, or otherwise.
  6. You will not use the Website for any illegal or unauthorized purpose.
  7. Your use of the Website will not violate any applicable law or regulation.

4. PROHIBITED ACTIVITIES

You may not access or use the Website for any purpose other than that for which we make the Website available. The Website may not be used in connection with any commercial endeavors except those that are specifically endorsed or approved between you and iCure.

As a user of the Website, you agree not to:

  1. Publishing any Website material in any other media.
  2. Selling, sublicensing, and or otherwise commercializing any Website material.
  3. Publicly performing and or showing any Website material.
  4. Using this Website in any way that is or may be damaging to this Website.
  5. Using this Website in any way that impacts user access to this Website.
  6. Using this Website contrary to applicable laws and regulations, or in any way may cause harm to the Website, or to any person or business entity.
  7. Engaging in any data mining, data harvesting, data extracting, or any other similar activity in relation to this Website.
  8. Using this Website to engage in any advertising or marketing.

5. NO WARRANTIES

This Website is provided “as is,” with all faults, and iCure expresses no representations or warranties, of any kind related to this Website or the materials contained on this Website. Also, nothing contained on this Website shall be interpreted as advising you.

6. LIMITATION OF LIABILITY

In no event shall iCure, nor any of its officers, directors, and employees shall be held liable for anything arising out of or in any way connected with your use of this Website whether such liability is under this agreement. iCure, including its officers, directors, and employees shall not be held liable for any indirect, consequential, or special liability arising out of or in any way related to your use of this Website.

7. INDEMNIFICATION

You hereby fully indemnify iCure from and against any and/or all liabilities, costs, demands, causes of action, damages, and expenses arising in any way related to your breach of any of the provisions of these Terms.

8. SEVERABILITY

If any provision of these Terms is found to be invalid under any applicable law, such provisions shall be deleted without affecting the remaining provisions herein.

9. VARIATION OF TERMS

iCure is permitted to revise these Terms at any time as it sees fit, and by using this Website you are expected to review these Terms on a regular basis.

10. ASSIGNMENT

iCure is allowed to assign, transfer, and subcontract its rights and/or obligations under these Terms without any notification. However, you are not allowed to assign, transfer, or subcontract any of your rights and/or obligations under these Terms.

11. ENTIRE AGREEMENT

These Terms constitute the entire agreement between iCure and you in relation to your use of this Website and supersede all prior agreements and understandings.

12. GOVERNING LAW & JURISDICTION

These Terms shall be governed by and construed in accordance with the laws of Switzerland, without regard to its conflict of law provisions.

The parties shall attempt to solve the matter amicably in mutual negotiations. In case of a non-amicable settlement that has been found between the parties, the Court of Geneva will be competent.

13. PRIVACY

Please refer to our Privacy Policy and Cookie Notice for the Data that we collected from the contact form and the Matomo cookie.

IMAGE ATTRIBUTION

In the development of our website, we have incorporated various icons to enhance visual appeal and convey information effectively. We extend our sincere appreciation to the talented designers and contributors who have generously shared their work with the community. Below is an acknowledgment of the resources we have utilized:

SVG Repo: A repository SVG icons. We integrated their icons into our website. Specifically:

  1. Work by author vmware, Key Badged SVG Vector under MIT License
  2. Work by author Twitter, Cloud SVG Vector under MIT License
  3. Work by author Garuda Technology, Node Js SVG Vector and React SVG Vector under MIT License

Thanks to the authors who contributed to the: SVGRepo, Unsplash, Maxipanels community.

iCure features logos from various products, libraries, technologies, and frameworks that our project interacts with. It is important to note that iCure does not hold any proprietary rights to these logos or the products they represent.

iCure SA

Contact: contact@icure.com

Last update: February 20th, 2024.

Information Security Policy

www.iCure.com

1. Introduction

The iCure universe is built on trust. Guaranteeing the confidentiality of the data that are entrusted to us is our highest priority.

The Information Security Policy of iCure abstracts the security concept that permeates every activity and abides by the ISO 27001:2013 requirements for Information Security, so that we ensure the security of the data that iCure and its clients manage.

Every employee, contractor, consultant, supplier and client of iCure is bound by our Information Security Policy.

2. Our Policy

iCure is committed to protecting the confidentiality, integrity and availability of the service it provides and the data it manages. iCure also considers protecting the privacy of its employees, partners, suppliers, clients and their customers as a fundamental security aspect.

iCure complies with all applicable laws and regulations regarding the protection of information assets and voluntarily commits itself to the provisions of the ISO 27001:2013.

3. Information Security Definitions

Confidentiality refers to iCure’s ability to protect information against disclosure. Attacks, such as network reconnaissance, database breaches or electronic eavesdropping or inadvertent information revealing through poor practices.

Integrity is about ensuring that information is not tampered with during or after submission. Data integrity can be compromised by accident or on purpose, by evading intrusion detection or changing file configurations to allow unwanted access.

Availability requires organizations to have up-and-running systems, networks, and applications to guarantee authorized users’ access to information without any interruption or waiting. The nature of data entrusted to us requires a higher-than-average availability.

Privacy is the right of individuals to control the collection, use, and disclosure of their personal information. Our privacy policies are based on the GDPR(https://gdpr-info.eu/) and can be augmented by added requirements of specific clients or law areas.

4. Risk Assessment

The main threats iCure is facing as a company are:

  1. Data Theft;
  2. Data Deletion;
  3. Denial of Service attacks;
  4. Malware;
  5. Blackmail and Extortion.

As providers of a solution used by developers active in Healthcare, we also have to anticipate the risks of:

  1. Attacks on our clients’ data, which could lead to major social damages and a loss of trust in our solution;
  2. Abuse of our solution by ill-intentioned clients, that could impact the quality of the service provided to the rest of our clients.

The motivation of the attackers in the latter cases can range from financial gain to political or ideological motivations.

A last risk is linked to the nature of the healthcare data we handle. We must ensure, that the data we handle are not used for purposes other than those for which they were collected:

A piece of data collected from a patient for the purpose of a medical consultation should not be available to third parties, not even a government agency.

5. Risk Management

The main principles we apply to manage the risks we face are:

  1. Confidentiality by design: All sensitive data is encrypted end-to-end before being stored in our databases. We do not have any access to the data we store. Our client’s customers are the only ones who can decrypt the data we store.
  2. Anonymization by design: Healthcare information that has to be stored unencrypted is always anonymized using end-to-end encryption scheme. This means that the link between the healthcare and administrative information must be encrypted.

Those two principles allow us to minimize the risks of data theft, blackmail, extortion, and coercion by government agency.

  1. Multiple real-time replicas, with automatic failover: We use a distributed database architecture to ensure that our data is available at all times. We use a master-master architecture, each data is replicated at least 3 times. Snapshots are taken every day to ensure that we can restore the data in case of a malevolent deletion event.
  2. Automatic password rotations: no single password can be used for more than 48 hours. Passwords are automatically rotated every 24 hours. In case of a password leak, we can limit the window of opportunity for an attack.

Those two principles allow us to minimise the risks of data deletion, denial of service attacks, and malware.

  1. Minimization of the attack surface: we deploy our systems in the most minimal way. We only expose the network services that are strictly necessary.
  2. Strict dependency management: we only use open-source software that is regularly updated and audited by the community. We favor dependency management software and providers that minimize the risk of supply chain poisoning.

Those two principles allow iCure to minimise the risks of intrusion by vulnerability exploit or supply chain attacks, two risks that could lead to data theft or data deletion.

6. Further Information

This policy is valid as of November 10th, 2022. For futher information please connect with us at privacy@icure.com

Impressum

iCure SA

Place de la Bourse-aux-Fleurs 2, Case postale 45, 1022 Chavannes-près-Renens, Switzerland

CHE-270.492.477

Website: https://icure.com/

Contact email: client@icure.com

Privacy request: privacy@icure.com

cookie

Deze website gebruikt cookies

We gebruiken slechts één cookie-applicatie voor intern onderzoek naar hoe we onze service voor alle gebruikers kunnen verbeteren. Het heet Matomo en slaat de informatie geanonimiseerd en voor beperkte tijd op in Europa. Voor meer details verwijzen we u naar onze Privacybeleid en .

Cookie Notice

www.iCure.com

1. Cookies basic information

Cookies are text files placed on your computer to collect standard Internet log information and visitor behavior information. When you visit our websites, we may collect information from you automatically through cookies or similar technology (for further information, visit allaboutcookies.org.)

You can set your browser not to accept cookies, and the above website tells you how to remove cookies from your browser. However, in a few cases, some of our website features may not function as a result.

2. Types of cookies

Types of cookies depending on the organisation managing them:

Own cookies: these cookies are sent to the user’s terminal from a computer or domain managed by the owner of the website from which the service requested by the user is provided.

Third-party cookies: these cookies are sent to the user’s terminal from a computer or domain not managed by the owner of the website from which the service requested by the user is provided, but by another organisation that processes the data obtained through the cookies. In addition, if the cookies are installed from a computer or domain managed by the Website owner but the information collected by them is managed by a third party, they will also be considered third-party cookies.

Types of cookies according to the length of time they remain active:

Session cookies: these cookies are designed to collect and store data when the user accesses a website. They are generally used to store information that only needs to be kept for the provision of the service requested by the user on a single occasion (for example, a list of products bought) and disappear when the user logs off or ends the session.

Persistent cookies: with these cookies, the data continue to be stored in the terminal and may be accessed and processed for a period defined by the person/entity responsible for the cookie, which may range from a few minutes to several years.

3. How and what cookies do we use

Strictly necessary/ functional cookies (these cookies are Mandatory): are essential to help you move around a website and use its features. They don’t collect information that identifies a visitor.

Analytical cookies (with your consent): collect information about how visitors use a website and help website owners improve site performance. They don’t collect information that identifies a visitor.

4. Cookies used on our website

Our web analytics open-source program, Matomo, uses two types of cookies for analyzing page usage: a session cookie ("MATOMO_SESSID") that lasts for 30 minutes and a persistent cookie ("_pk_id.xxx") that remains beyond the browsing session, allowing anonymous tracking of website usage for up to 13 months (without collecting personal information). Matomo temporarily stores user data, including IP addresses, on our server in anonymized form for evaluation before deletion. This data is solely used for our personnal analysis, with no sharing with third parties.

  • Host: Matomo
  • Cookie name: MATOMO_SESSID
  • Expiration: Session 30 min

  • Host: Matomo
  • Cookie name: _pk_id.xxx
  • Expiration: 13 months

For the purposes of analyzing website usage and to optimize its services. The legal basis for the use of Matomo is Article 6, 1 (a) of the GDPR (consent).

5. Users preference

The user can, at any time, allow, block or delete the cookies installed on his/her device by changing the settings on the browser installed on his/her computer:

  • Chrome Chrome Settings -> Advanced -> Privacy -> Content settings. For more information, consult Google support or your browser Help.
  • Explorer or Edge: Tools -> Internet options -> Privacy -> Settings. For more information, consult Microsoft support or your browser Help.
  • Firefox Firefox: Tools – > Options -> Privacy -> History -> Customised Settings. For more information, consult Mozilla support or your browser Help
  • Safari Safari Preferences -> Security. For more information, consult Apple support or your browser Help.
  • You will not access the Website through automated or non-human means, whether through a bot, script, or otherwise.
  • You will not use the Website for any illegal or unauthorized purpose.
  • Your use of the Website will not violate any applicable law or regulation.

6. Withdrawing consent

The user may withdraw his/her consent relating to the Cookies Policy at any time, and may delete the cookies stored on his/her device by adjusting his/her internet browser settings, as described above.

7. Cookie settings

This Cookies Policy may be modified when required by the legislation in force at any time or when there is a change in the type of cookies used on the website. For this reason, we recommend that you review this policy every time you access our website so that you are appropriately informed of how and why we use cookies.

8. Contact

Please contact us with any questions or comments about this Policy, your Personal Data, and our use and disclosure practices by email at privacy@icure.com

iCure SA

Contact: contact@icure.com

Last update: September 13th, 2023

Quality Policy

www.iCure.com

At iCure SA, we are committed to excellence in all aspects of our work. Our quality policy is designed to provide a framework for measuring and improving our performance within the QMS.

1. Purpose of the Organization

The purpose of the QMS is to ensure consistent quality in the design, development, production, installation, and delivery of Data processing, security, archival, technical support and protection solutions for medical device software, while ensuring we meet customer and regulatory requirements. The document applies to all documentation and activities within the QMS. Users of this document are members of the iCure Management Team involved in the processes covered by the scope.

2. Compliance and Effectiveness

We are committed to complying with all applicable regulatory and statutory requirements, including ISO 13485: 2016 and ISO 27001:2013. We strive to maintain and continually improve the effectiveness of our quality management system.

3. Quality Objectives

Our quality objectives are set within the framework of this policy and as defined by our Software Development Lifecycle and are reviewed regularly to ensure they align with our business goals. These objectives serve as benchmarks for measuring our performance and guide our decision-making processes.

4. Communication

We ensure that our quality policy is communicated and understood at all levels of the organization. We encourage every member of our team to uphold these standards in their daily work whether they are employees, contractors, consultants, suppliers, clients or any other person involved in building our medical data management software.

5. Continuing Suitability

We regularly review our quality policy to ensure it remains suitable for our organization. This includes considering new regulatory requirements, feedback from customers, and changes in our business environment. By adhering to this policy, we aim to enhance customer satisfaction, improve our performance, and contribute to the advancement of medical technology

iCure SA

Contact: contact@icure.com

Last update: April 17th, 2024